A simplified process for the manufacture of AZD0530, a potent SRC kinase inhibitor

Organic Process Research and Development

Volumn 15, Issue 3, 2011, Pages 688-692

  Raw, Steven A ^a   Taylor, Brian A ^a   Tomasi, Simone ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EFFICIENT PROCESS; SRC-KINASE;

ENZYMES;

MANUFACTURE;

EID: 79957533898     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op200079g     Document Type: Article

References (16)

1. Ford, J. G.; McCabe, J. F.; O'Kearney-McMullan, A.; O'Keefe, P.; Pointon, S. M.; Powell, L.; Purdie, M.; Withnall, J. WO/2006/064217, 2006.
2. Ford, J. G.; Pointon, S. M.; Powell, L.; Siedlecki, P. S.; Baum, J.; Chubb, R.; Fieldhouse, R.; Muxworthy, J.; Nivlet, A.; Stenson, R.; Warwick, E. Org. Process Res. Dev. 2010, 14, 1078-1087
3. Ford, J. G.; O'Kearney-McMullan, A.; Pointon, S. M.; Powell, L.; Siedlecki, P. S.; Purdie, M.; Withnall, J.; O'Keefe, P.; Wood, F. Org. Process Res. Dev. 2010, 14, 1088-1093
4. Hennequin, L. F, A.; Ple, P. WO/2001/94341, 2001.
5. Hennequin, L. F.; Allen, J.; Breed, J.; Curwen, J.; Fennell, M.; Green, T. P.; Lambert van der Brempt, C.; Morgentin, R.; Norman, R. A.; Olivier, A.; Otterbein, L.; Ple, P. A.; Warin, N.; Costello, G. J. Med. Chem. 2006, 49, 6465-6488
6. Box, G. E. P.; Hunter, J. S.; Hunter, W. G. Statistics for Experimenters: Design, Discovery and Innovation, 2 nd ed.; Wiley Interscience: 2005; Chapter 5, pp 173-222.
7. Reichardt, C. Solvents and Solvent Effects in Organic Chemistry, 3 rd ed.; Wiley-VCH: 2003; Chapter 4, pp 93-145.
8. NIST Chemistry WebBook: http://webbook.nist.gov/chemistry/.
9. Müller, L.; Mauthe, R. J.; Riley, C. M.; Andino, M. M.; De Antonis, D.; Beels, C.; DeGeorge, J.; De Knaep, A. G. M.; Ellison, D.; Fagerland, J. A.; Frank, R.; Fritschel, B.; Galloway, S.; Harpur, E.; Humfrey, C. D. N.; Jacks, A. S.; Jagota, N.; Mackinnon, J.; Mohan, G.; Ness, D. K.; O'Donovan, M. R.; Smith, M. D.; Vudathala, G.; Yotti, L. Regulatory Toxicology and Pharmacoclogy 2006, 44, 198-211 and references therein
10. EMEA Committee for Medicinal Products for Human Use "Guideline on the Limits of Genotoxic Impurities" EMEA/CHMP/QWP/251344/2006
11. EMEA Safety Working Party "Question & Answers on the CHMP Guideline on the Limits of Genotoxic Impurities" EMEA/CHMP/SWP/431994/2007, revision 2.
12. Maron, D. M.; Ames, B. N. Mutat. Res. 1983, 113, 173-215
13. Material gave satisfactory spectroscopic and chromatographic data upon analysis (see ref 1).
14. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A.;, Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; M. A. Al-Laham; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian 03, Revision B.05; Gaussian, Inc.; Wallingford, CT; 2004.
15. Scott, A. P.; Radom, L. J. Phys. Chem. 1996, 100, 16502-16513
16. Mennucci, B.; Cancès, E.; Tomasi, J. J. Phys. Chem. B 1997, 101, 10506-10517